4//SEC Filing
Meisner Derek M 4
Accession 0001628280-26-001262
CIK 0001576885other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:30 PM ET
Size
13.2 KB
Accession
0001628280-26-001262
Insider Transaction Report
Form 4
Meisner Derek M
Chief Legal Officer & Corp Sec
Transactions
- Sale
Common Stock
2026-01-05$1.96/sh−4,000$7,838→ 157,127 total - Sale
Common Stock
2026-01-06$1.97/sh−7,097$13,961→ 150,030 total - Sale
Common Stock
2026-01-06$1.97/sh−3,801$7,477→ 146,229 total - Sale
Common Stock
2026-01-07$1.99/sh−1,700$3,379→ 144,529 total - Sale
Common Stock
2026-01-07$1.99/sh−10,070$20,035→ 134,459 total
Footnotes (7)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2024.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9200 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $2.0000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025.
- [F5]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025.
- [F6]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0200. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0250. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001752461
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 9:30 PM ET
- Size
- 13.2 KB